MASITINIB FOR THE TREATMENT OF SEVERELY SYMPTOMATIC INDOLENT AND SMOLDERING SYSTEMIC MASTOCYTOSIS: A RANDOMIZED, PLACEBO-CONTROLLED, INTERNATIONAL, PHASE 3 STUDY

HAEMATOLOGICA(2016)

Cited 0|Views10
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined